Evidence map›Paper›PMID 29509930›Full record

ArticleNeuro-oncology2018

Quality improvement in neurology: Neuro-Oncology Quality Measurement Set.

Justin T Jordan, Amy E Sanders, Terri Armstrong, Tony Asher, Amy Bennett, Erin Dunbar, Nimish Mohile, P Leia Nghiemphu, Timothy R Smith, Douglas E Ney

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Justin T JordanPappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA.
Amy E SandersDepartment of Neurology, SUNY Upstate Medical University, Syracuse, NY.
Terri ArmstrongNeuro-Oncology Branch, Center for Clinical Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Tony AsherDepartment of Neurological Surgery, Carolinas Medical Center Carolina Neurosurgery and Spine Associates, Charlotte, NC.
Amy BennettAmerican Academy of Neurology, Minneapolis, MN.
Erin DunbarDepartment of Neuro-Oncology, Piedmont Brain Tumor Center, Atlanta, GA.
Nimish MohileDepartment of Neurology, University of Rochester, Rochester, NY.
P Leia NghiemphuDepartment of Neurology, UCLA, Los Angeles, CA.
Timothy R SmithCushing Neurosurgical Outcomes Center, Brigham & Women's Hospital, Harvard Medical School, Boston, MA.
Douglas E NeyDepartments of Neurology and Neurosurgery, University of Colorado School of Medicine, Aurora, CO.

Funding

Outcomes and Risk of Rare TumorsZIABC011837 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ARMSTRONG, TERRI S. · 2018 to 2024
$2.7M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Quality ImprovementBrain NeoplasmsDelivery of Health CareHealth ServicesHumansNeurologyQuality of Health Care

Identifiers

PMID29509930
PMCPMC5909638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.